Interface (TILE) Q4 2025: Nora Rubber Billings Jump 17%, Automation Drives Margin Expansion
Interface delivered a record year, propelled by the One Interface strategy, with Nora rubber billings up 17% and margin expansion outpacing the sector. Automation, mix shift toward resilient flooring, and disciplined SG&A spending are reinforcing operating leverage. Management’s 2026 outlook targets further productivity gains and new product launches, but tariff volatility and macro uncertainty remain key watchpoints.
Summary
- Automation and Product Mix Advance Margins: Efficiency gains and premium product launches are driving gross margin expansion above prior targets.
- Healthcare and Education Outperform: Segment-focused selling and new offerings are fueling double-digit growth in resilient categories.
- 2026 Leans into Innovation: Noravant launch and global automation rollout underpin guidance for continued share gains and margin stability.
Performance Analysis
Interface’s record 2025 was defined by broad-based growth and margin expansion, underpinned by the One Interface strategy—a unified global and local selling model that integrates Carpetile, LVT (luxury vinyl tile), and Nora rubber into a single customer-facing platform. Currency-neutral net sales rose 4% for the year, with all three product categories growing in both price and volume. Americas led with 5% growth, while EAAA (Europe, Africa, Asia, Australia) delivered 2% despite macro headwinds. Notably, Nora rubber billings surged 17% and healthcare segment billings rose 21% globally, signaling successful penetration of higher-value verticals.
Margin expansion was a standout, with adjusted gross profit margin reaching 39% for the year—helped by automation, favorable mix, and pricing discipline. This included a nonrecurring inventory reserve benefit, but even excluding this, margins exceeded historical averages. SG&A costs rose with sales and inflation, but remained flat as a percentage of sales, reflecting tight cost controls. Cash from operations increased and capital allocation favored reinvestment in automation, debt reduction, and shareholder returns via buybacks and a dividend increase.
- Healthcare and Education Tailwind: Double-digit growth in both segments, with healthcare up 21% and education up 8% for the year, drove mix improvement.
- Automation and Robotics Payoff: Investments in U.S. and Nora plant automation lifted productivity and are being expanded globally to Europe and Australia.
- Balanced Capital Allocation: Cash flow growth enabled $18M in buybacks and a dividend raise, while $124M of debt was repaid and CapEx increased to fund further automation.
Corporate office growth remained flat, offset by retail softness, but Interface’s diversified segment approach and new product platforms are positioning the company to capture multi-year demand in resilient flooring.
Executive Commentary
"2025 was a record year for Interface, as net sales, adjusted operating income, and adjusted EBITDA reached their highest levels in the company's history, driven by a One Interface strategy."
Laurel Hurd, Chief Executive Officer
"Full-year adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing, improved mix, and manufacturing efficiencies, partially offset by higher input costs."
Bruce Hausman, Chief Financial Officer
Strategic Positioning
1. One Interface Model Drives Cross-Selling and Segment Diversification
The One Interface strategy—combining sales teams across product lines—has accelerated cross-selling, especially in healthcare and education, and deepened customer relationships. This approach is unlocking share gains in verticals where Interface’s design, performance, and sustainability credentials are highly valued.
2. Automation and Global Supply Chain Optimization
Investments in automation and robotics across U.S., Nora, and now European and Australian facilities are central to Interface’s productivity and margin expansion. These initiatives reduce waste, improve efficiency, and support higher service levels, providing a durable cost advantage and scalability for new product lines like Noravant.
3. Product Innovation and Market Expansion
The launch of Noravant—PVC-free, design-forward rubber sheet flooring—targets premium resilient markets and is expected to meaningfully expand the addressable market, especially in healthcare and education. The Open Air platform and mid-priced LVT offerings are also enabling incremental growth without margin dilution, supporting broad customer access and incremental share.
4. Sustainability as Differentiator
Sustainability leadership remains a core pillar, with Interface offering the highest recycled and bio-based material content in the industry and new tools like carbon calculators for customers. The company’s carbon-negative rubber prototype and ongoing recognition as a sustainability leader provide both market differentiation and regulatory insulation.
5. Disciplined Capital Allocation and Balance Sheet Strength
Interface’s capital allocation balances reinvestment in innovation and automation with shareholder returns and debt reduction. The refinancing of the credit facility, debt repayments, and opportunistic buybacks signal financial flexibility and confidence in future cash generation.
Key Considerations
Interface’s 2025 performance demonstrates the power of a unified go-to-market model, disciplined cost management, and targeted innovation. The company is leveraging its operational improvements and market segmentation to drive durable growth and margin expansion, but ongoing macro and input cost volatility require close attention.
Key Considerations:
- Expanding Addressable Market: Noravant and Open Air platforms are unlocking new customer segments and geographies, particularly in healthcare and education.
- Margin Leverage from Automation: Ongoing automation investments are delivering productivity gains, with wraparound benefits expected as global rollout continues.
- Tariff Volatility: Tariff-related costs diluted 2025 margins by 20 basis points and are expected to be a 50 basis point headwind in 2026, with day-to-day uncertainty requiring vigilance.
- SG&A Discipline: Tight gating of SG&A spend and variable compensation tied to revenue are preserving operating leverage even as the company invests in growth.
- Balanced Customer Base: Low customer concentration and a focus on renovation (80% of business) provide resilience against project-specific volatility.
Risks
Tariff and input cost volatility remain significant headwinds, with management covering dollar-for-dollar impacts but facing ongoing margin dilution. Macro uncertainty, particularly in international markets and the retail segment, could dampen volume growth. Execution risk exists as Interface scales automation globally and launches new product categories, while competitive intensity in corporate and retail channels may limit share gains.
Forward Outlook
For Q1 2026, Interface guided to:
- Net sales of $315M to $325M
- Adjusted gross profit margin of approximately 38%
- Adjusted SG&A expenses of about $94M
For full-year 2026, management guided to:
- Net sales of $1.42B to $1.46B
- Adjusted gross profit margin of 38.5% to 39%
- SG&A expenses of 26.2% to 26.4% of net sales
- Capital expenditures of $55M
Management underscored:
- Healthy Backlog: Backlog up 7% year to date, supporting Q1 and full-year confidence.
- Noravant Contribution: New product expected to begin revenue contribution in Q4 2026, with multi-year growth runway.
Takeaways
Interface’s unified commercial model and automation investments are yielding clear financial and strategic benefits, particularly in resilient segments like healthcare and education. The company’s disciplined capital allocation and innovation pipeline underpin 2026 guidance, but investors should monitor tariff and macro risks.
- Segment Diversification Pays Off: Healthcare and education growth is offsetting flat corporate and soft retail, validating Interface’s market segmentation strategy.
- Margin Expansion Sustainable: Automation and mix shift to premium and mid-tier resilient products are supporting margin targets even as input costs and tariffs fluctuate.
- Innovation Pipeline Critical: Noravant’s ramp and further product launches will be key to sustaining outperformance as legacy categories mature.
Conclusion
Interface exits 2025 with record results and a robust operational foundation. The One Interface strategy, automation, and new product platforms position the company for continued share gains and margin resilience, though execution and external cost pressures must be navigated carefully.
Industry Read-Through
Interface’s results highlight the structural advantages of cross-segment sales models and automation in commercial flooring. The shift toward resilient, sustainable, and design-forward products is accelerating, with healthcare and education leading demand. Tariff volatility and input cost inflation are sector-wide risks, but those with operational flexibility and innovation pipelines—like Interface—are best positioned to outperform. Competitors should note the benefits of segment-focused selling and disciplined SG&A control to maintain margin stability in a mixed macro backdrop.